Medical News

RSS

InTouch Health to feature at FiReGlobal's conference

FiReGlobal : West Coast is proud to announce that InTouch Health has been selected as a FiReStar company to be featured at the FiReGlobal : West Coast conference.

12 Oct 2009

Danbury Office of Physician Services selects athenahealth’s revenue cycle management services

athenahealth, Inc., a leading provider of internet-based business services to physician practices, today announced that the Danbury Office of Physician Services (DOPS), one of Connecticut’s largest multi-specialty physician group practices has selected athenahealth’s revenue cycle management service, athenaCollectorSM, for its 250 medical provider organization.

12 Oct 2009

Depomed announces results from BREEZE 1 and 2 Phase 3 clinical trials of Serada

Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.

12 Oct 2009

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

In a continuing series called “Exciting Biologies” Cell Press, Massachusetts General Hospital and La Fondation Ipsen collaborate to offer annual meetings designed to highlight emerging intersections in biomedical research and promote interactions between scientists from converging disciplines. This third meeting, held in Buenos Aires between the 8th and 10th of October, focused on “Biology in Balance”.

12 Oct 2009

GF Capital Private Equity Fund purchases Airborne

Airborne, Inc., maker of dietary supplements that support immune health, today announced that it has been purchased by GF Capital Private Equity Fund, LP, a New York City-based private equity firm. Terms of the deal were not disclosed. Stockton Road Capital, LLC, advised and partnered with GF Capital with respect to this investment.

12 Oct 2009

Amedisys to acquire the home health operations of Hackensack University Medical Center

Amedisys, Inc., one of America's leading home health and hospice nursing companies, today announced that it has completed the discussions disclosed in a press release dated September 10, 2009 and has signed a definitive agreement to acquire the home health operations of Hackensack University Medical Center.

12 Oct 2009

RNs and RPNs at SMGH vote to select Ontario Nurses' Association as their union

Registered Nurses (RNs) and Registered Practical Nurses (RPNs) at the Strathroy Middlesex General Hospital (SMGH) have voted to make the Ontario Nurses' Association (ONA) their union.

12 Oct 2009

Study finds that stranger homicide by people with schizophrenia rare

International study led by Sydney researchers shows homicides of strangers by people with schizophrenia are exceptionally rare and unpredictable events

12 Oct 2009

First evidence that personalized medicine leads to better outcomes

A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy.

12 Oct 2009

State representatives to announce patient-centered plan for health care reform

On Tuesday, October 13, in response to national calls for an alternative to Obamacare, representatives from 33 state think tanks will announce their "patient-centered" plan for health care reform.

12 Oct 2009

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

The Biotechnology Industry Organization (BIO) provided comments yesterday to the Secretary’s Advisory Committee on Genetics, Health and Society regarding its draft report on Gene Patenting and Licensing and Their Impact on Patient Access to Genetic Tests. The report makes several recommendations that would restrict the ability to obtain or undermine the enforceability of patents and exclusive licenses with respect to genetic tests.

12 Oct 2009

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.

12 Oct 2009

UK Bioscientists create GM knowledge pipeline to help fight future food insecurity in African nations

UK Bioscientists are transferring GM knowledge and technology from the developed to the developing world to help fight future food insecurity in Sub-Saharan Africa.

12 Oct 2009

COPD Management Program for South Region TRICARE beneficiaries

Humana Military Healthcare Services, a wholly owned subsidiary of Humana Inc., announced today an additional benefit available for South Region TRICARE beneficiaries. The Chronic Obstructive Pulmonary Disease (COPD) Management Program offers telephonic education and coaching by dedicated registered nurses.

12 Oct 2009

Collaborative effort to premiere nation’s second Mobile Emergency Room

In partnership with the Emergency Medical Services (EMS) Agency of Los Angeles County, Long Beach Memorial Medical Center and Miller Children’s Hospital will premiere the nation’s second Mobile Emergency Room (ER) unit today at the 25th Anniversary of the Long Beach International City Bank Marathon and Half Marathon.

12 Oct 2009

President of Consumers Union calls health reform 'vital'

This week, Consumers Union, the nonprofit organization that publishes Consumer Reports magazine, stepped into the health care debate by airing a 30-second television ad supporting an overhaul.

12 Oct 2009

Breast cancer patients who achieve pathological complete response have better outcomes

Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center.

12 Oct 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

12 Oct 2009

ECA President denounces falsely attributed misleading claims about e-cigarettes

Matt Salmon, President of the Electronic Cigarette Association (ECA), today denounced a quotation attributed to him by Epiphany Media Group in a press release dated September 14, 2009. The falsely attributed quotation conveys the mistaken impression that some e-cigarette products have been approved by the FDA for consumer use. Salmon underscored the ECA’s commitment to abide by FDA regulations.

12 Oct 2009

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona.

12 Oct 2009

Medical News

InTouch Health to feature at FiReGlobal's conference

Danbury Office of Physician Services selects athenahealth’s revenue cycle management services

Depomed announces results from BREEZE 1 and 2 Phase 3 clinical trials of Serada

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

GF Capital Private Equity Fund purchases Airborne

Amedisys to acquire the home health operations of Hackensack University Medical Center

RNs and RPNs at SMGH vote to select Ontario Nurses' Association as their union

Study finds that stranger homicide by people with schizophrenia rare

First evidence that personalized medicine leads to better outcomes

State representatives to announce patient-centered plan for health care reform

BIO disagrees with recommendations of the draft report on Gene Patenting and Licensing

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

UK Bioscientists create GM knowledge pipeline to help fight future food insecurity in African nations

COPD Management Program for South Region TRICARE beneficiaries

Collaborative effort to premiere nation’s second Mobile Emergency Room

President of Consumers Union calls health reform 'vital'

Breast cancer patients who achieve pathological complete response have better outcomes

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

ECA President denounces falsely attributed misleading claims about e-cigarettes

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News